Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rybelsus
Pharma
Novo's oral semaglutide shows heart benefits
Armed with the positive phase 3 readout, Novo said it plans to file Rybelsus for cardiovascular outcomes approvals “around the turn of the year.”
Angus Liu
Oct 21, 2024 10:09am
A look at the top 10 pharma drug ad spenders
Jun 7, 2024 9:08am
The top 10 pharma drug ad spenders for 2023
Jun 3, 2024 3:00am
Diabetes, weight loss TV spending climbs amid wrestle for share
Mar 27, 2024 6:56am
Novo Nordisk plans massive manufacturing campus near Dublin
Dec 28, 2023 11:36am
Novo to invest $2.3B to expand production of GLP-1s in France
Nov 27, 2023 10:40am